POTENTIATION OF RADIATION LETHALITY IN MOUSE MELANOMA-CELLS BY MILD HYPERTHERMIA AND CHLOROQUINE

被引：8

作者：

DJORDEVIC, B

LANGE, CS

ROTMAN, M

机构：

[1] Department of Radiation Oncology, SUNY Health Science Center at Brooklyn, Brooklyn, NY, 11203, Box 1212

来源：

MELANOMA RESEARCH | 1992年 / 2卷 / 5-6期

关键词：

CHLOROQUINE; HYPERTHERMIA; MELANOMA; RADIATION SENSITIZATION;

D O I：

10.1097/00008390-199212000-00005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

To test the hypothesis that radiosensitization by combined mild hyperthermia and chloroquine may be increased by the presence of melanin in treated cells, Cloudman melanotic mouse melanoma S91/6 cells, and the amelanotic S91/amel cells were incubated during a 3 h post-irradiation period with 0.03 mM chloroquine at 41-degrees-C. A considerable increase in radiation lethality was observed (radiation potentiation factor >1.6) in both cases. Addition of 0.1 mM isobutyl-methyl xanthine (IBMX), a promoter of melanin synthesis, to the growth medium of S91/6 cells 10 days before irradiation, did not further increase the lethality of radiation followed by combined heat and chloroquine treatment. Under these conditions, toxicity to unirradiated cells was slight. On the other hand, 10 muM chloroquine showed similar toxicity to unirradiated B-16 mouse melanoma cells, but did not increase radiation lethality. Factors other than melanin content therefore play a role in the potentiation of radiation lethality by mild hyperthermia and chloroquine.

引用

页码：321 / 326

页数：6

共 25 条

[1]

Habermalz H.J., Fisher J.J., Radiation therapy of malignant melanoma: Experience with high individual treatment doses, Cancer, 38, pp. 2258-2262, (1976)

[2]

Perez C.A., Brady L.W., Principle and Practice of Radiation Oncology, (1992)

[3]

Rate W.R., Solin L.J., Turrisi A.T., Palliative radiotherapy for metastatic malignant melanoma: Brain metastases, and spinal cord compression, Int J Radiat Oncol Biol Phys, 15, pp. 859-864, (1988)

[4]

Braverman A.S., Medical oncology in the 1990s, Lancet, 337, pp. 901-902, (1991)

[5]

Benjamin R.A., Gutterman J.U., McKelvey E.M., Et al., Systemic chemotherapy for melanoma, Neoplasms of the Skin and Malignant Melanoma, pp. 461-470, (1976)

[6]

Stehlin J.S., Giovanella B., Delpolyi P.D.F., Erson R.F., Results of hyperthermic perfusion for melanoma of the extremities, Surg Gynecol Obstet, 140, pp. 339-340, (1975)

[7]

Klein E.S., Ben-Ari G.Y., Isolation perfusion with cisplatin for malignant melanoma of the limbs, Cancer, 59, pp. 1068-1071, (1987)

[8]

Edwards M.J., Soong S.J., Boddie A.W., Et al., Isolated limb perfusion for localized melanoma of the extremity, Arch Surg, 125, pp. 317-321, (1990)

[9]

Coit D.G., Hyperthermic isolation limb perfusion for malignant melanoma: A review, Cancer Invest, 10, pp. 277-284, (1992)

[10]

Beierwaltes W.H., Gill S.P., Labelled chloroquine analogs in the diagnosis and treatment of ocular and dermal melanomas, Malignant Melanoma, (1981)

← 1 2 3 →